Related Experiment Video
Updated: May 2, 2026
11:53
Predicting Gene Silencing Through the Spatiotemporal Control of siRNA Release from Photo-responsive Polymeric Nanocarriers
Published on: July 21, 2017
6.6K
Temperature-responsive DNA-gated nanocarriers for intracellular controlled release
Zhengze Yu1, Na Li, Peipei Zheng
1College of Chemistry, Chemical Engineering and Materials Science, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Shandong Normal University, Jinan 250014, P.R. China. tangb@sdnu.edu.cn.
Chemical Communications (Cambridge, England)
|February 21, 2014
Summary
Researchers developed novel temperature-responsive nanocarriers using mesoporous silica and DNA valves. These nanocarriers enable controlled drug release, offering a promising platform for advanced therapeutics.
Area of Science:
- Materials Science
- Nanotechnology
- Biomedical Engineering
Background:
- Controlled drug delivery systems are crucial for therapeutic efficacy.
- Mesoporous silica nanoparticles (MSNs) offer high surface area and tunable porosity for drug encapsulation.
- Developing stimuli-responsive systems for precise drug release remains a significant challenge.
Purpose of the Study:
- To design and synthesize novel temperature-responsive nanocarriers for controlled release applications.
- To utilize reversible single-stranded DNA (ssDNA) as a smart valve mechanism for nanocarrier gating.
- To investigate the performance of these nanocarriers under varying temperature conditions.
Main Methods:
- Synthesis of mesoporous silica nanoparticles (MSNs).
- Functionalization of MSNs with reversible single-stranded DNA (ssDNA) valves.
- Encapsulation of model drug molecules within the MSNs.
- Evaluation of temperature-triggered drug release kinetics.
- Characterization of nanocarrier structure and stability.
Main Results:
- Successfully constructed temperature-responsive nanocarriers with integrated ssDNA valves.
- Demonstrated precise control over drug release in response to specific temperature changes.
- Observed reversible gating behavior of the ssDNA valves.
- Confirmed efficient drug loading and release profiles.
Conclusions:
- The developed mesoporous silica nanocarriers with ssDNA valves represent a novel and effective platform for temperature-controlled drug delivery.
- This strategy offers a versatile approach for designing smart nanomedicines with tunable release profiles.
- The findings have significant implications for the development of advanced therapeutic systems.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
177
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
177
01:24Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
01:23Modified-Release Drug Delivery Systems: Classification
315
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
315
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
172
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
172
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
137
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
137